Dr. Alfaris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3045 Arlington Ave
Toledo, OH 43614Phone+1 419-383-4244
Education & Training
- University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2014
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2010 - 2012
- King Saud University College of MedicineClass of 2003
Certifications & Licensure
- PA State Medical License 2012 - 2022
- MA State Medical License 2015 - 2016
- OH State Medical License 2009 - 2012
Publications & Presentations
PubMed
- 5 citationsDefinition and diagnostic criteria of clinical obesity.Francesco Rubino, David E Cummings, Robert H Eckel, Ricardo V Cohen, John P H Wilding
The Lancet. Diabetes & Endocrinology. 2025-03-01 - Experiences and overall impact reported by people living with obesity: results from a multinational study.Esther Artime, Swarna Khare, Sarah Zimner-Rapuch, Josefine Redig, Caragh Flannery
SAGE Open Medicine. 2025-01-01 - 6 citationsGLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review.Nasreen Alfaris, Stephanie Waldrop, Veronica Johnson, Brunna Boaventura, Karla Kendrick
Eclinicalmedicine. 2024-09-01
Press Mentions
- ‘UAE Obesity Conference’ Returns to Abu Dhabi for Its Fourth Year Conference Highlights Obesity as a Disease and Not a ChoiceNovember 20th, 2022
- The Future of Obesity Care: Combination Therapy, Patient-Focused TreatmentNovember 5th, 2021
- Sleep, Mood Improves After Substantial Weight LossJune 24th, 2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: